It seems that Fifth Column operatives want to hide some of the facts about the massive taxpayer expenditure on the failed Covid19 jabs.
Here I will concentrate on Pfizer BioNTech that has achieved market dominance.
The production processes for materials used in the Phase 1 trial were not the same as those used in the Phase 2/3 trials, and most likely contributed to variations reported in Serious Adverse Events for various Lots or Batches.
The European Medicines Agency made a Major Objection1 to Pfizer/BioNTech changing the process to use toxic E. coli instead of RT-PCR for the commercial product. Pfizer replied "as the cutoff date for the clinical Interim Analysis (IA) was changed, the IA doesn’t include data from subjects dosed with Process 2 material, and the Company does not expect to have Process 2 included in the Final Analysis dataset"
This document will be key in numerous Court cases around the world.
The same wording appears on page 57 of the EMA document.2
